318 related articles for article (PubMed ID: 30017813)
1. Generation of high quality of hepatocyte-like cells from induced pluripotent stem cells with Parp1 but lacking c-Myc.
Huang CS; Lin HC; Lu KH; Wu WW; Yang YC; Yang YP; Chiang CH; Hsieh JH; Chang YL; Lee SD
J Chin Med Assoc; 2018 Oct; 81(10):871-877. PubMed ID: 30017813
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc.
Chiou SH; Jiang BH; Yu YL; Chou SJ; Tsai PH; Chang WC; Chen LK; Chen LH; Chien Y; Chiou GY
J Exp Med; 2013 Jan; 210(1):85-98. PubMed ID: 23277454
[TBL] [Abstract][Full Text] [Related]
4. Improvement of non-alcoholic steatohepatitis by hepatocyte-like cells generated from iPSCs with Oct4/Sox2/Klf4/Parp1.
Chien Y; Huang CS; Lin HC; Lu KH; Tsai PH; Lai YH; Chen KH; Lee SD; Huang YH; Wang CY
Oncotarget; 2018 Apr; 9(26):18594-18606. PubMed ID: 29719629
[TBL] [Abstract][Full Text] [Related]
5. Artd1/Parp1 regulates reprogramming by transcriptional regulation of Fgf4 via Sox2 ADP-ribosylation.
Weber FA; Bartolomei G; Hottiger MO; Cinelli P
Stem Cells; 2013 Nov; 31(11):2364-73. PubMed ID: 23939864
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
7. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
9. Improvement of carbon tetrachloride-induced acute hepatic failure by transplantation of induced pluripotent stem cells without reprogramming factor c-Myc.
Chang HM; Liao YW; Chiang CH; Chen YJ; Lai YH; Chang YL; Chen HL; Jeng SY; Hsieh JH; Peng CH; Li HY; Chien Y; Chen SY; Chen LK; Huo TI
Int J Mol Sci; 2012; 13(3):3598-3617. PubMed ID: 22489170
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of human foreskin fibroblast-derived induced pluripotent stem cells into hepatocyte-like cells.
Wang J; Zhao P; Wan Z; Jin X; Cheng Y; Yan T; Qing S; Ding N; Xin S
Cell Biochem Funct; 2016 Oct; 34(7):475-482. PubMed ID: 27569862
[TBL] [Abstract][Full Text] [Related]
11. Dynamic regulation of human endogenous retroviruses mediates factor-induced reprogramming and differentiation potential.
Ohnuki M; Tanabe K; Sutou K; Teramoto I; Sawamura Y; Narita M; Nakamura M; Tokunaga Y; Nakamura M; Watanabe A; Yamanaka S; Takahashi K
Proc Natl Acad Sci U S A; 2014 Aug; 111(34):12426-31. PubMed ID: 25097266
[TBL] [Abstract][Full Text] [Related]
12. Promotion of direct reprogramming by transformation-deficient Myc.
Nakagawa M; Takizawa N; Narita M; Ichisaka T; Yamanaka S
Proc Natl Acad Sci U S A; 2010 Aug; 107(32):14152-7. PubMed ID: 20660764
[TBL] [Abstract][Full Text] [Related]
13. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
14. Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells.
Wang L; Chen Y; Guan C; Zhao Z; Li Q; Yang J; Mo J; Wang B; Wu W; Yang X; Song L; Li J
Stem Cell Res Ther; 2017 Nov; 8(1):245. PubMed ID: 29096702
[TBL] [Abstract][Full Text] [Related]
15. Using Oct4:MerCreMer Lineage Tracing to Monitor Endogenous Oct4 Expression During the Reprogramming of Fibroblasts into Induced Pluripotent Stem Cells (iPSCs).
Greder LV; Post J; Dutton JR
Methods Mol Biol; 2016; 1357():97-110. PubMed ID: 25687297
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
[TBL] [Abstract][Full Text] [Related]
17. Generation of Induced Pluripotent Stem Cells in Rabbits.
Afanassieff M; Tapponnier Y; Savatier P
Methods Mol Biol; 2016; 1357():149-72. PubMed ID: 25413017
[TBL] [Abstract][Full Text] [Related]
18. Induction of dental pulp-derived induced pluripotent stem cells in the absence of c-Myc for differentiation into neuron-like cells.
Chang YC; Li WC; Twu NF; Li HY; Lo WL; Chang YL; Lee YY; Lin CF; Shih YH; Chen MT
J Chin Med Assoc; 2014 Dec; 77(12):618-25. PubMed ID: 25441769
[TBL] [Abstract][Full Text] [Related]
19. H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells.
Kunitomi A; Yuasa S; Sugiyama F; Saito Y; Seki T; Kusumoto D; Kashimura S; Takei M; Tohyama S; Hashimoto H; Egashira T; Tanimoto Y; Mizuno S; Tanaka S; Okuno H; Yamazawa K; Watanabe H; Oda M; Kaneda R; Matsuzaki Y; Nagai T; Okano H; Yagami KI; Tanaka M; Fukuda K
Stem Cell Reports; 2016 Jun; 6(6):825-833. PubMed ID: 27237376
[TBL] [Abstract][Full Text] [Related]
20. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
